English
Home > Products > Gentamicin Injection formulation

China Gentamicin Injection formulation Factory

We always believe that one's character decides products' quality, the details decides products' quality ,with the REALISTIC,EFFICIENT AND INNOVATIVE team spirit for Gentamicin Injection formulation,CAS NO 1403-66-3,1403-66-3,Gentamicin formulation, We are generally looking ahead to forming effective business associations with new clientele around the world.
Gentamicin Injection formulation, Our company warmly invites domestic and overseas customers to come and negotiate business with us. Let us join hands to create a brilliant tomorrow! We're looking forward to cooperating with you sincerely to achieve a win-win situation. We promise to try our best to supply you with high quality and efficient services.

Related Products

Hot Products

  • Levofloxacin Tablets

    Levofloxacin Tablets

    Product Name:Levofloxacin hydrochloride Tablets
    Dosage:250mg
    Dosage:500mg
    Application:Antibiotic
  • 1,2,4-Trichloro-5-nitrobenzene

    1,2,4-Trichloro-5-nitrobenzene

    Product Name:1,2,4-Trichloro-5-nitrobenzene
    Molecular Formula:C6H2Cl3NO2
    Molecular Weight:226.44
    CAS Registry Number:89-69-0
  • Everolimus

    Everolimus

    Product Name:Everolimus
    Molecular Formula:C53H83NO14
    Molecular Weight;958.22
    CAS Registry Number;159351-69-6
  • N-Boc-3-Pyrrolidinone

    N-Boc-3-Pyrrolidinone

    Product Name:N-Boc-3-Pyrrolidinone
    Molecular Formula:C9H15NO3
    Molecular Weight:185.22
    CAS Registry Number:101385-93-7
  • 3,5-Difluoropyridine-2,6-diamine

    3,5-Difluoropyridine-2,6-diamine

    Product Name:3,5-Difluoropyridine-2,6-diamine
    Molecular Formula:C5H5F2N3
    Molecular Weight:145.11
    CAS Registry Number:247069-27-8
  • Nidanibu diethylsulfonate

    Nidanibu diethylsulfonate

    Product Name:Nidanibu diethylsulfonate
    Molecular Formula:C33H39N5O7S
    Molecular Weight;649.76
    CAS Registry Number;656247-18-6
  • Related Blog
  • Reviews

  • Prostate Cancer and Darolutamide

    Prostate cancer results from uncontrollable growth of cancer cells in the prostate gland. The prostate gland is located below the bladder and in front of the rectum, and is only found in males. Almost all prostate cancers (more than 95% of primary prostate cancers) develop from the gland cells and are known as adenocarcinomas (National Cancer Institute, 2017).

  • Gilteritinib Fumarate

    Sandoo Pharmaceutica is a professional pharmaceutical intermediates manufacturer. We provide good quality Gilteritinib Fumarate Cas: 1254053-43-4. Welcome and we look forward to your inquiry!

  • FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC

    On November 2, 2018, the Food and Drug Administration granted accelerated approval to lorlatinib (LORBRENA, Pfizer, Inc.) for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

  • Baloxavir marboxil

    Baloxavir marboxil is used to treat flu symptoms caused by influenza virus in people who have had symptoms for no more than 48 hours. Baloxavir marboxil will not treat the common cold. Baloxavir marboxil is for adults and children who are at least 12 years old and weigh at least 88 pounds (40 kilograms).

  • How is a drug produced?

    ​There are so many different drugs ,with different color /shape ( like capsule ,tablet or Infusion) and price . Here we would like to explain , what makes it so different? How is a drug produced?

  • What is Coenzyme Q10 CAS NO.303-98-0

    Coenzyme Q10 (CAS NO.303-98-0 ) is a fat-soluble antioxidant, which can activate the nutrition of human cells and cellular energy, and has the functions of improving human immunity, enhancing antioxidation, delaying ageing and enhancing human vitality.

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept